BeOne Medicines AG ONC
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 62.32% | 4.24% | 241.88% | -46.73% | 32.36% |
| Total Depreciation and Amortization | -4.08% | -1.22% | 14.41% | -3.66% | 19.70% |
| Total Amortization of Deferred Charges | 1,382.29% | -8.61% | 12.75% | 0.52% | -73.26% |
| Total Other Non-Cash Items | 14.49% | -5.27% | -19.38% | 7.76% | 9.43% |
| Change in Net Operating Assets | -199.25% | 136.88% | -215.65% | 63.52% | 1,768.48% |
| Cash from Operations | 9.91% | 129.87% | -51.76% | 3.68% | 52.71% |
| Capital Expenditure | -28.02% | 32.64% | -8.71% | 21.97% | -9.72% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 97.33% | -363.40% | -480.69% | 31.68% | 94.78% |
| Cash from Investing | 27.54% | -8.44% | -18.72% | 22.20% | 26.02% |
| Total Debt Issued | -- | -100.00% | -93.25% | -- | -100.00% |
| Total Debt Repaid | 54.01% | -123.16% | 99.02% | -18,281.82% | 96.31% |
| Issuance of Common Stock | 896.40% | -53.73% | 24.07% | -76.11% | 142.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 8.00% | 99.14% | -304.32% | -100.16% | -- |
| Cash from Financing | 1,788.04% | -108.82% | -29.19% | -89.92% | 2,644.53% |
| Foreign Exchange rate Adjustments | -47.07% | 2.67% | -16.59% | 133.84% | -57.81% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 37.07% | 75.26% | -51.16% | -62.32% | 418.39% |